HOME >> BIOLOGY >> NEWS
Synchrotron could help save the Tassie devil

Australias new $200m synchrotron in Melbourne could contribute to the fight to save the Tasmanian devil from the outbreak of facial tumour disease currently decimating devil populations, according to Dr Jeff Church from CSIRO Textile and Fibre Technology in Geelong.

Dr Church says he will use the synchrotron to see if the disease causes any biochemical changes in the devils which could be detected in their hair before the disease becomes apparent.

If we find a consistent change, it could lead to the development of a test which will allow detection of the cancer before the tumours become evident, he says. This would make any quarantine strategy easier to establish, as well as much more efficient.

The idea is based on Australian research showing disease-related changes in the composition of human hair. The suggestion is that similar changes could occur in Tasmanian devils hair when the facial tumour disease is triggered. But, the theory needs to be fully tested, Dr Church says. It might work or it might not.

The synchrotrons infra-red beamline combined with a microscope and spectrometer which detects how different materials absorb and reflect the radiation can be used to determine if the composition of hair differs between diseased animals and healthy ones.

The infra-red spectrum tells us about protein and fat structure and whether its changing, Dr Church says. But the technology to do such work using a synchrotron is comparatively new, and the Australian facility is one of relatively few around the world where it is available.

If a diagnostic test for the facial tumour disease using the synchrotron does look possible, only having a machine nearby would make it viable. Having to queue-up for time on a synchrotron at least nine hours flying time from Tasmania more likely further would make the whole thing very difficult, particularly in terms of biosecurity concerns because we would need to transport
'"/>

Contact: Heather Forward
heather.forward@csiro.au
61-352-464-085
CSIRO Australia
1-Aug-2007


Page: 1 2

Related biology news :

1. Newly created cancer stem cells could aid breast cancer research
2. New system of wastewater treatment could reduce the size of treatment plants by half
3. Discovery of new protein could provide new understanding of male fertility
4. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
5. How a pain in the neck could be bad for your blood pressure
6. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
7. Fish eyes could hold clue to repairing damaged retinas in humans
8. New aerogels could clean contaminated water, purify hydrogen for fuel cells
9. MIT model could predict cells response to drugs
10. System to analyze beating heart stem cells could lead to heart attack treatments
11. Gene expression pattern could lead to improved treatment of pediatric septic shock

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... 2020 , ... BioFactura, Inc. today announced a $1 million ... & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense (DoD). ... efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs for rapid ...
(Date:7/10/2020)... (PRWEB) , ... July 08, 2020 , ... ... on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 ... a comparability study, but what is the most effective way to complete one? ...
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, a global ... of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga prefecture of ... located in Kakegawa, the new 60,000-square-foot facility will provide customers with flexible clinical ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 30, 2020 , ... ... industry, today announced the release of its signature product called Beacon - ... (MSLs) and other field medical professionals. , Beacon helps MSLs streamline ...
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/10/2020)... , ... July 08, 2020 , ... ... and products, announces a significant expansion of laboratory operations through its COVID-19 ... agencies implementing testing programs. , Bode-CARES provides a turnkey solution ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a ... of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. ... lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine ...
Breaking Biology Technology:
Cached News: